An observational study in TCM Syndrome of Chronic Atrophic Gastritis, sponsored by Beijing University of Chinese Medicine. Status unknown at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2021-02-01.
Sponsored by Beijing University of Chinese Medicine · Observational
Among 25 studies in Gastritis, Atrophic with a site in China — 14 open to participants now, 15 under way, none of them phase 3. Gastritis, Atrophic · China.
Among the 25 studies in Gastritis, Atrophic with a site in China, this one is the 3rd largest by planned enrollment of the 16 observational ones that give a count, is the only one that started in 2014, is one of 16 observational ones, and was the 8th registered.
75 studies on the registry are indexed under Gastritis, Atrophic; 37 are open to participants now.
Browse Gastritis, Atrophic studies →14 of the 25 studies in Gastritis, Atrophic with a site in China are open now. Recruiting first, the newest first:
Jilin University · Sites in China
Jilin University · Sites in China
The Third Affiliated hospital of Zhejiang Chinese Medical University · Sites in China
Shanghai Jiao Tong University School of Medicine · Sites in China
Affiliated Hospital to Academy of Military Medical Sciences · Sites in China
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 24 Gastritis, Atrophic studies recruiting now, 13 (54%) set no upper age limit and 5 (21%) stop at 75 or younger; 0 take children under 18; 10 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
25 studies; the count open now beside each. This study's row is marked.
First in 2009; this study’s year is marked. 1 started in 2014.
This study's planned enrollment of 2,000 is above the median of 509 across 54 observational studies indexed under Gastritis, Atrophic.
Median enrollment 180 across the 9 interventional studies, 358 across the 16 observational. Of the 5 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 25 have an industry lead sponsor. The 10 most frequent:
Beijing University of Chinese Medicine is the lead sponsor of 32 studies on the registry; 8 are open to participants now.
Beijing University of Chinese Medicine has 4 studies filed under Gastritis, Atrophic — fewer than ten, so there is no comparison to draw.
2 of the studies in Gastritis, Atrophic with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07152860Yi LiangEvaluation of the Efficacy of Electroacupuncture in the Treatment of Chronic Atrophic Gastritis | 2026-12-30 |
| NCT07391800Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineCompound Granules of Hedyotis Diffusa for Chronic Atrophic Gastritis | 2027-07-31 |
Among the 25 studies in Gastritis, Atrophic with a site in China, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Chronic atrophic gastritis (CAG) is acknowledged as the precancerous stage of gastric cancer (GC). The present study aims to explore Traditional Chinese Medicine (TCM) syndrome features in different stages of CAG malignant transformation respectively. The proposed study is a cross-sectional study based participant survey conducted in 4 hospitals in Beijing, China. After obtaining informed consent, a total of 2000 study patients will be recruited on-site in hospitals.
CAG is acknowledged as the precancerous stage GC. Active treatment of CAG is vital in arresting malignant transformation. Traditional Chinese medicine (TCM) has been widely used in treating CAG and preventing GC in China. To date, few study has been conducted to assess the syndrome features of different stages of CAG malignant transformation combining TCM indicators.
The present study aims to explore TCM syndrome features in different stages of CAG malignant transformation. The proposed study is a registry study based participant survey conducted in 4 hospitals in Beijing, China. After obtaining informed consent, a total of 2000 eligible study patients will berecruited on-site in hospitals.
Comparative analysis of prevalence of presenting TCM features is conducted using frequency analysis and chi-squared tests, and expressed with composition ratios. Exploratory factor analysis,correspondence analysis, association rule analysis, hierarchical clustering analysis, and complex system entropy clustering analysis will be performed respectively for validating features of syndrome in different stages of CAG malignant transformation.
Previous reports on TCM syndrome features for CAG exist, but no studies have been undertaken base on large-sampled study design and detailed analysis in different stages of CAG malignant transformation respectively.
The outcome of our study has the potential to clerify core TCM pathogenesis of CAG, facilitate early intervention, and promote optimization of treatment strategies of CAG malignant transformation by TCM.
This is a multicenter cross-sectional study conducted in 4 hopitals in Beijing, China,lleaded by Beijing University of Chinese Medicine. According to the inclusion and exclusion criteria, 2000 eligible participants will be involved in this study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
TCM syndrome
According to the symptoms and physical signs of patients to determine the syndrome
Time frame: one time at involvement (1 day)
Started Jan 2014 (actual). Primary completion is estimated for Dec 2021, 95 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Beijing University of Chinese Medicine